crabp ii rabbit polyclonal antibody  (Proteintech)

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling

doi: 10.1186/s13046-022-02261-0

Figure Lengend Snippet: CRABP-II regulates cholesterol metabolic genes expression through cooperation with HuR. ( A ) Molecular and cellular function analysis by IPA software (Qiagen) based on gene expression microarray profiling. The altered lipid synthesis and accumulation functions upon CRABP-II knockout were listed. ( B ) Heat map of altered cholesterol metabolic genes. ( C, D, E ) Cholesterol metabolic genes expression assessed by Q-PCR. ( F ) Correlation between cholesterol metabolic genes and CRABP-II expression in human pancreatic cancer specimens by Pearson’s product-moment correlation coefficient analysis (PPMCC). Data shown here are combination of Pei Pancreas and Badea Pancrease datasets ( n = 75) from Oncomine. ( G ) Interaction between CRABP-II and HuR identified by co-immuprecipitation (co-IP). GR4000 cell lysis was incubated with anti-CRABP-II rabbit polyclonal antibody and the pull down proteins were separated and blotted with anti-HuR mouse monoclonal antibody. ( H ) Half-life of SREBP-1c mRNA assessed by actinomycin D treatment following with Q-PCR. ( I ) RNA-immunoprecipitation (RIP). The down pulled SREBP-1c mRNA from flagged-CRABP-II transfected CIIKO cells and empty vector transfected cells were assessed by Q-PCR. The actin mRNA was used as control. The experiment was repeated three times and the error bars present standard deviation (SD). **, p < 0.01

Article Snippet: Antibodies used in this study include: CRABP-II mouse mAbs (Millipore, MAB5488), CRABP-II rabbit polyclonal antibody (Proteintech, 10,225–1-AP), HuR (3A2, Santa Cruz, sc-5261), Flotilin-2 (Santa Cruz, sc-28320), GAPDH (Santa Cruz, sc-365062), and Actin (Santa Cruz, sc-1615), anti-Flag M2 mAb (Sigma, F9291), anti-Flag agarose beads (Clontech, #635,686), Ki67 (SP6, ThermoFisher, RM-9106-S0), ADRP (Novus, NB110-40,877), Caspas3 (Cell Signaling, #9662), PARP (Cell Signaling, #9542), AKT (Cell Signaling, #4691), mTOR (Cell Signaling, #2983), S6 (Cell Signaling, #2217), pAKT (S473, Cell Signaling, #9018), pmTOR (Cell Signaling, #5536), pS6 (Cell Signaling, #4858), and pGSK3β (Cell Signaling, #5558).

Techniques: Expressing, Cell Function Assay, Software, Gene Expression, Microarray, Knock-Out, Co-Immunoprecipitation Assay, Lysis, Incubation, RNA Immunoprecipitation, Transfection, Plasmid Preparation, Control, Standard Deviation

Journal: RSC Advances

Article Title: Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity

doi: 10.1039/c8ra00744f

Figure Lengend Snippet: CRABP-II and FABP5 expression patterns in MB cells with and without RA treatment. (A) CRABP-II and FABP5 mRNA expressions were measured using real-time RT-PCR. ** p < 0.01. (B) Immunofluorescence staining for CRABP-II and FABP5 in RA-treated MB cells. Magnified regions of each image are shown in the insets. (C) Western blot analysis of UW228-2 and Med-3 cells treated with and without RA. Grayscale quantitative analysis was performed on the Western blot results. * p < 0.05. Scale bar = 100 μm.

Article Snippet: Rabbit polyclonal antibodies against CRABP-II (ProteinTech 10225-1-AP) or FABP5 (ProteinTech 12348-1-AP), were applied overnight at 4 °C.

Techniques: Expressing, Quantitative RT-PCR, Immunofluorescence, Staining, Western Blot

Journal: RSC Advances

Article Title: Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity

doi: 10.1039/c8ra00744f

Figure Lengend Snippet: Expression patterns of CRABP-II and FABP5 in MB tissues. Immunohistochemical profiling of CRABP-II and FABP5 expression patterns in classic and large-cell MBs. The staining patterns were scored as CRABP-II↑/FABP5↓ (FABP5 down-regulated) and CRABP-II↓/FABP5↑ (FABP5 up-regulated) based on the labeling intensity of these two proteins in individual cases. The insets illustrate regions at higher magnification. Scale bar = 50 μm.

Article Snippet: Rabbit polyclonal antibodies against CRABP-II (ProteinTech 10225-1-AP) or FABP5 (ProteinTech 12348-1-AP), were applied overnight at 4 °C.

Techniques: Expressing, Immunohistochemical staining, Staining, Labeling

Journal: RSC Advances

Article Title: Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity

doi: 10.1039/c8ra00744f

Figure Lengend Snippet: Tissue microarray-based immunohistochemical staining of CRABP-II and FABP5 in human medulloblastomas

Article Snippet: Rabbit polyclonal antibodies against CRABP-II (ProteinTech 10225-1-AP) or FABP5 (ProteinTech 12348-1-AP), were applied overnight at 4 °C.

Techniques: Microarray, Immunohistochemical staining, Staining

Journal: RSC Advances

Article Title: Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity

doi: 10.1039/c8ra00744f

Figure Lengend Snippet: Summary of CRABP-II/FABP5 patterns in the cases analyzed and possible predicted outcomes of RA treatment

Article Snippet: Rabbit polyclonal antibodies against CRABP-II (ProteinTech 10225-1-AP) or FABP5 (ProteinTech 12348-1-AP), were applied overnight at 4 °C.

Techniques: